Independent data review commences for Phase 2 trial of psilocybin-assisted psychotherapy for anxiety
January 18, 2023 08:00 ET
|
Incannex Healthcare
MELBOURNE, Australia, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’), a pharmaceutical company developing proprietary...
Optimi Health Expands Functional Mushroom Sales Network With Additional Brokers, Distribution Agreements
January 17, 2023 09:00 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end Canadian-based drug manufacturer...
Kaya Enters Jamaica’s Legal Psilocybin Market
January 11, 2023 08:30 ET
|
NUGL, Inc.
KINGSTON, Jamaica and LOS ANGELES, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Kaya Group ("Kaya" or "the Company") (OTC: NUGL), the first medicinal Ganja herb house in the Caribbean and holistic,...
Optimi Health Announces Re-Appointments to Board of Directors
January 10, 2023 16:15 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), is pleased to announce that Mr. Bryan Safarik,...
Silo Pharma Advances Clinical Study Analyzing Effects of Psilocybin on Inflammation
January 10, 2023 10:15 ET
|
Silo Pharma, Inc.
Parkinson's disease, bipolar disorder, and chronic pain targeted in study Study aims to support psilocybin as a potential therapeutic for inflammatory disorders ENGLEWOOD CLIFFS,...
Reset Pharmaceuticals Appoints Innes Meldrum as President and Chief Executive Officer
January 05, 2023 08:00 ET
|
Reset Pharmaceuticals Inc.
NEW YORK, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Reset Pharmaceuticals, Inc. (Reset Pharma), a privately held biotechnology company focused on the development of innovative treatments to address mental...
Ketamine Media Scheduled to Launch North America's Largest Psilocybin Awareness Network
December 21, 2022 10:30 ET
|
Ketamine Media
KNOXVILLE, Tenn., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Ketamine Media announced today that it is in the final stages of launching its digital ecosystem of premium online properties to raise awareness...
Galexxy Holdings Inc., Announces its Intention to Pursue Dual Listing on the Upstream Platform
November 16, 2022 09:00 ET
|
Galexxy Holdings Inc.
Newport Beach, CALIFORNIA, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Galexxy Holdings Inc., (“Galexxy” or “Company”) (OTC: GXXY) announced today that following a recent board meeting, the directors of the...
Mindset Pharma and PharmAla Biotech Enter into Exclusive Sales Agreement
November 16, 2022 07:30 ET
|
PharmAla Biotech
VANCOUVER, British Columbia, Nov. 16, 2022 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA), a biotechnology company focused on the research, development, and manufacturing...
Reset Pharmaceuticals announces appointment of neuroscience industry leader Lisa Deschamps to the Board of Directors
November 02, 2022 08:00 ET
|
Reset Pharmaceuticals Inc.
NEW YORK, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Reset Pharmaceuticals, Inc. (Reset Pharma), a privately held biotechnology company focused on the development and commercialization of novel...